For those who don't improve, the options exist but accessing them on the NHS requires persistence, advocacy, and often a specialist referral
Excitingly, researchers are also exploring long-term effects of GLP-1 agonists that extend beyond conventional diabetes treatment
No in-person visits needed
Users frequently describe diminished hunger, increased satiety, reduced high-calorie desires, improved energy, and enhanced health markers in blood pressure, cholesterol, and glucose levels
However, it is important to highlight that the GBS study used an older version of the SomaScan assay that included a smaller number of proteomic markers (1,297), and that the comparison used 2 year post-GBS data versus the 1-year follow-up data in the STEP trials